---
title: "BioNTech’s rally on Moderna trial win likely to fade, Leerink says"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296380155.md"
description: "Leerink Partners analyst Daina Graybosch predicts BioNTech's recent 21% rally will fade, despite Moderna and Merck's Phase 3 trial success for a melanoma therapy. She argues investors will absorb poor read-through for BioNTech, whose iNEST program has been negatively impacted by prior negative data."
datetime: "2026-08-19T16:16:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296380155.md)
  - [en](https://longbridge.com/en/news/296380155.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296380155.md)
---

# BioNTech’s rally on Moderna trial win likely to fade, Leerink says


### Related Stocks

- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [BNTX.US](https://longbridge.com/en/quote/BNTX.US.md)
- [MRNX.US](https://longbridge.com/en/quote/MRNX.US.md)
- [MRNY.US](https://longbridge.com/en/quote/MRNY.US.md)

## Related News & Research

- [Moderna stock soars on cancer vaccine success](https://longbridge.com/en/news/296405393.md)
- [Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test](https://longbridge.com/en/news/296382081.md)
- [Health care roundup: Market talk](https://longbridge.com/en/news/296381776.md)
- [REG - GraniteShares Fin. Graniteshares 3x S M Granite 3X shrt Mod£ - 3SMO - SOL3 - Early termination notice](https://longbridge.com/en/news/296371392.md)
- [Moderna surges on trial win for cancer shot; William Blair upgrades](https://longbridge.com/en/news/296370751.md)